Erratum: Protective effects of a polyphenol-rich extract from syzygium cumini (L.) skeels leaf on oxidative stress-induced diabetic rats (Oxidative Medicine and Cellular Longevity (2018) 2018 (5386079) DOI: 10.1155/2018/5386079);Protective effects of a polyphenol-rich extract from Syzygium cumini (L.) Skeels leaf on oxidative stress-induced diabetic rats

Oxidative Medicine and Cellular Longevity

Volumn 2018, Issue , 2018, Pages

  Chagas, Vinicyus Teles ^a   De Sousa Coelho, Rafaella Moraes Rego ^a   Gaspar, Renato Simões ^a   Da Silva, Samira Abdalla ^a   Mastrogiovanni, Mauricio ^b   De Jesus Mendonça, Cáritas ^a   De Souza Ribeiro, Maria Nilce ^a   De Andrade Paes, Antonio Marcus ^a   Trostchansky, Andres ^b  

^a FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^b UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; GALLIC ACID; LIPOXYGENASE; MYRICETIN; QUERCETIN; SYZYGIUM CUMINI EXTRACT; TRIACYLGLYCEROL; ANTIOXIDANT; INSULIN; PLANT EXTRACT; POLYPHENOL;

ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETOGENESIS; DPPH RADICAL SCAVENGING ASSAY; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NONHUMAN; OXIDATIVE STRESS; PLANT LEAF; RAT; TANDEM MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CELL LINE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; SYZYGIUM; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CELL LINE; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; INSULIN; MALE; OXIDATIVE STRESS; PLANT EXTRACTS; PLANT LEAVES; POLYPHENOLS; RATS; RATS, WISTAR; SYZYGIUM; TANDEM MASS SPECTROMETRY; TRIGLYCERIDES;

EID: 85055165167     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2019/5785798     Document Type: Erratum

References (46)

1. T. V. Fiorentino, A. Prioletta, P. Zuo, and F. Folli, “Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases,” Current Pharmaceutical Design, vol. 19, no. 32, pp. 5695-5703, 2013.
2. M. M. Delmastro and J. D. Piganelli, “Oxidative stress and redox modulation potential in type 1 diabetes,” Clinical & Developmental Immunology, vol. 2011, article 593863, 15 pages, 2011.
3. V. T. Chagas, L. M. França, S. Malik, and A. M. d. A. Paes, “Syzygium cumini (L.) skeels: a prominent source of bioactive molecules against cardiometabolic diseases,” Frontiers in Pharmacology, vol. 6, p. 259, 2015.
4. M. T. Pepato, D. M. Mori, A. M. Baviera, J. B. Harami, R. C. Vendramini, and I. L. Brunetti, “Fruit of the jambolan tree (Eugenia jambolana Lam.) and experimental diabetes,” Journal of Ethnopharmacology, vol. 96, no. 1-2, pp. 43-48, 2005.
5. A. Helmstadter, “Syzygium cumini (L.) Skeels (Myrtaceae) against diabetes - 125 years of research,” Die Pharmazie - An International Journal of Pharmaceutical Sciences, vol. 63, no. 2, pp. 91-101, 2008.
6. M. S. Baliga, H. P. Bhat, B. R. V. Baliga, R. Wilson, and P. L. Palatty, “Phytochemistry, traditional uses and pharmacology of Eugenia jambolana Lam. (black plum): a review,” Food Research International, vol. 44, no. 7, pp. 1776-1789, 2011.
7. A. Rzepecka-Stojko, J. Stojko, A. Kurek-Gorecka et al., “Polyphenols from bee pollen: structure, absorption, metabolism and biological activity,” Molecules, vol. 20, no. 12, pp. 21732-21749, 2015.
8. J. Guillermo Gormaz, N. Valls, C. Sotomayor, T. Turner, and R. Rodrigo, “Potential role of polyphenols in the prevention of cardiovascular diseases: molecular bases,” Current Medicinal Chemistry, vol. 23, no. 2, pp. 115-128, 2016.
9. S. Srivastava and D. Chandra, “Pharmacological potentials of Syzygium cumini: a review,” Journal of the Science of Food and Agriculture, vol. 93, no. 9, pp. 2084-2093, 2013.
10. E. S. De Brito, M. C. P. De Araujo, R. E. Alves, C. Carkeet, B. A. Clevidence, and J. A. Novotny, “Anthocyanins present in selected tropical fruits: acerola, jambolão, jussara, and guajiru,” Journal of Agricultural and Food Chemistry, vol. 55, no. 23, pp. 9389-9394, 2007.
11. A. Bopp, K. S. De Bona, L. P. Belle, R. N. Moresco, and M. B. Moretto, “Syzygium cumini inhibits adenosine deaminase activity and reduces glucose levels in hyperglycemic patients,” Fundamental & Clinical Pharmacology, vol. 23, no. 4, pp. 501-507, 2009.
12. J. R. Sanches, L. M. França, V. T. Chagas et al., “Polyphenol-rich extract of Syzygium cumini leaf dually improves peripheral insulin sensitivity and pancreatic islet function in monosodium L-glutamate-induced obese rats,” Frontiers in Pharmacology, vol. 7, p. 48, 2016.
13. S. Lenzen, “The mechanisms of alloxan- and streptozotocin-induced diabetes,” Diabetologia, vol. 51, no. 2, pp. 216-226, 2008.
14. B. Sharma, C. Balomajumder, and P. Roy, “Hypoglycemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic rats,” Food and Chemical Toxicology, vol. 46, no. 7, pp. 2376-2383, 2008.
15. S. Lenzen, “Oxidative stress: the vulnerable β-cell,” Biochemical Society Transactions, vol. 36, no. 3, pp. 343-347, 2008.
16. L. Guo, J. . H. Lian, W. Ji, W. . R. Hu, G. . L. Wu, and B. . Q. Gong, “Establishment of a cell-based drug screening system for identifying selective down-regulators of mPGES-1,” Inflammation Research, vol. 55, no. 3, pp. 114-118, 2006.
17. L. E. Simental-Mendia, M. Rodriguez-Moran, and F. Guerrero-Romero, “The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects,” Metabolic Syndrome and Related Disorders, vol. 6, no. 4, pp. 299-304, 2008.
18. I. U. Pueyo and M. I. Calvo, “Assay conditions and validation of a new UV spectrophotometric method using microplates for the determination of polyphenol content,” Fitoterapia, vol. 80, no. 8, pp. 465-467, 2009.
19. L. L. Chaillou, H. A. Herrera, and J. F. Maidana, “Estudio del propoleos de Santiago del Estero, Argentina,” Ciência e Tecno-logia de Alimentos, vol. 24, no. 1, pp. 11-15, 2004.
20. C. A. Torres, N. M. Davies, J. A. Yanez, and P. K. Andrews, “Disposition of selected flavonoids in fruit tissues of various tomato (lycopersicon esculentum mill.) genotypes,” Journal of Agricultural and Food Chemistry, vol. 53, no. 24, pp. 9536-9543, 2005.
21. A. Gordon, E. Jungfer, B. A. da Silva, J. G. S. Maia, and F. Marx, “Phenolic constituents and antioxidant capacity of four underutilized fruits from the Amazon region,” Journal of Agricultural and Food Chemistry, vol. 59, no. 14, pp. 7688-7699, 2011.
22. n and HPLC-PAD-ESI-IT-MS combined with NMR,” Molecules, vol. 18, no. 7, pp. 8402-8416, 2013.
23. H. B. Liu, D. Yu, S. C. Shin, H. R. Park, J. K. Park, and K. M. Bark, “Spectroscopic properties of quercetin derivatives, quercetin-3-O-rhamnoside and quercetin-3-O-rutinoside, in hydro-organic mixed solvents,” Photochemistry and Photobiology, vol. 85, no. 4, pp. 934-942, 2009.
24. J. S. Park, I. S. Kim, S. U. Rehman, C. S. Na, and H. H. Yoo HPLC Determination of bioactive flavonoids in Hovenia dulcis fruit extracts,” Journal of Chromatographic Science, vol. 54, no. 2, pp. bmv114-bmv135, 2016.
25. J. A. Larrauri, C. Sanchez-Moreno, P. Ruperez, and F. Saura-Calixto, “Free radical scavenging capacity in the aging of selected red Spanish wines,” Journal of Agricultural and Food Chemistry, vol. 47, no. 4, pp. 1603-1606, 1999.
26. R. Re, N. Pellegrini, A. Proteggente, A. Pannala, M. Yang, and C. Rice-Evans, “Antioxidant activity applying an improved ABTS radical cation decolorization assay,” Free Radical Biology & Medicine, vol. 26, no. 9-10, pp. 1231-1237, 1999.
27. Y. Yoshie-Stark, J. Bez, Y. Wada, and A. Wasche, “Functional properties, lipoxygenase activity, and health aspects of Lupinus albus protein isolates,” Journal of Agricultural and Food Chemistry, vol. 52, no. 25, pp. 7681-7689, 2004.
28. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248-254, 1976.
29. J. Sun, F. Liang, Y. Bin, P. Li, and C. Duan, “Screening non-colored phenolics in red wines using liquid chromatography/ ultraviolet and mass spectrometry/mass spectrometry libraries,” Molecules, vol. 12, no. 3, pp. 679-693, 2007.
30. P. Sharma and R. Singh, “Effect of Momordica dioica fruit extract on antioxidant status in liver, kidney, pancreas, and serum of diabetic rats,” Pharmacognosy Research, vol. 6, no. 1, pp. 73-79, 2014.
31. H. N. Choi, M. J. Kang, S. J. Lee, and J. I. Kim, “Ameliorative effect of myricetin on insulin resistance in mice fed a high-fat, high-sucrose diet,” Nutrition Research and Practice, vol. 8, no. 5, pp. 544-549, 2014.
32. C. J. Chang, T. F. Tzeng, S. S. Liou, Y. S. Chang, and I. M. Liu, “Myricetin increases hepatic peroxisome proliferator-activated receptor α protein expression and decreases plasma lipids and adiposity in rats,” Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 787152, 11 pages, 2012.
33. M. B. Dusane and B. N. Joshi, “Seeds of Syzygium cumini (L.) Skeels: potential for islet regeneration in experimental diabetes,” Zhong Xi Yi Jie He Xue Bao, vol. 9, no. 12, pp. 1380-1387, 2011.
34. R. Arun, M. V. D. Prakash, S. K. Abraham, and K. Premkumar, “Role of Syzygium cumini seed extract in the chemoprevention of in vivo genomic damage and oxidative stress,” Journal of Ethnopharmacology, vol. 134, no. 2, pp. 329-333, 2011.
35. L. Boulekbache-Makhlouf, E. Meudec, M. Chibane et al., “Analysis by high-performance liquid chromatography diode array detection mass spectrometry of phenolic compounds in fruit of Eucalyptus globulus cultivated in Algeria,” Journal of Agricultural and Food Chemistry, vol. 58, no. 24, pp. 12615-12624, 2010.
36. K. S. de Bona, G. Bonfanti, P. E. R. Bitencourt et al., “Protective effect of gallic acid and Syzygium cumini extract against oxidative stress-induced cellular injury in human lymphocytes,” Drug and Chemical Toxicology, vol. 39, no. 3, pp. 256-263, 2016.
37. Z. P. Ruan, L. L. Zhang, and Y. M. Lin, “Evaluation of the antioxidant activity of Syzygium cumini leaves,” Molecules, vol. 13, no. 10, pp. 2545-2556, 2008.
38. R. S. Eshwarappa, R. S. Iyer, S. R. Subbaramaiah, S. A. Richard, and B. L. Dhananjaya, “Antioxidant activity of Syzygium cumini leaf gall extracts,” BioImpacts: BI, vol. 4, no. 2, pp. 101-107, 2014.
39. H. Hossain, S. E. Rahman, P. N. Akbar, T. A. Khan, M. M. Rahman, and I. A. Jahan, “HPLC profiling, antioxidant and in vivo anti-inflammatory activity of the ethanol extract of Syzygium jambos available in Bangladesh,” BMC Research Notes, vol. 9, no. 1, p. 191, 2016.
40. F. Shi, X. N. Zeng, X. D. Cao et al., “Design and diversity-oriented synthesis of novel 1,4-thiazepan-3-ones fused with bioactive heterocyclic skeletons and evaluation of their antioxidant and cytotoxic activities,” Bioorganic & Medicinal Chemistry Letters, vol. 22, no. 1, pp. 743-746, 2012.
41. D. O. Kim, K. W. Lee, H. J. Lee, and C. Y. Lee, “Vitamin C equivalent antioxidant capacity (VCEAC) of phenolic phytochemicals,” Journal of Agricultural and Food Chemistry, vol. 50, no. 13, pp. 3713-3717, 2002.
42. P. Cos, L. Ying, M. Calomme et al., “Structure−activity relationship and classification of flavonoids as inhibitors of xan-thine oxidase and superoxide scavengers,” Journal of Natural Products, vol. 61, no. 1, pp. 71-76, 1998.
43. M. V. Turman, P. J. Kingsley, C. A. Rouzer, B. F. Cravatt, and L. J. Marnett, “Oxidative metabolism of a fatty acid amide hydrolase-regulated lipid, arachidonoyltaurine,” Biochemistry, vol. 47, no. 12, pp. 3917-3925, 2008.
44. S. J. Persaud, D. Muller, V. D. Belin et al., “The role of arachidonic acid and Its metabolites in insulin secretion from human islets of langerhans,” Diabetes, vol. 56, no. 1, pp. 197-203, 2007.
45. S. A. Tersey, E. Bolanis, T. R. Holman, D. J. Maloney, J. L. Nadler, and R. G. Mirmira, “Minireview: 12-lipoxygenase and islet β-cell dysfunction in diabetes,” Molecular Endocrinology, vol. 29, no. 6, pp. 791-800, 2015.
46. R. Adili, B. E. Tourdot, K. Mast et al., “First selective 12-LOX inhibitor, ML355, impairs thrombus formation and vessel occlusion in vivo with minimal effects on hemostasis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 37, no. 10, pp. 1828-1839, 2017.